What laboratory tests should be ordered for a 20-year-old patient with splenomegaly who has had infectious mononucleosis?

Laboratory Workup for 20-Year-Old with Splenomegaly and Prior Mononucleosis

Order a complete blood count with differential, comprehensive metabolic panel including liver enzymes, and EBV-specific antibody testing (VCA IgG, VCA IgM, and EBNA) to assess for chronic active EBV infection or complications of prior mononucleosis. 1

Initial Laboratory Testing

Essential First-Line Tests

• Complete Blood Count with Differential: Look for persistent lymphocytosis (>50% lymphocytes), atypical lymphocytes (>10%), or concerning cytopenias that might indicate chronic active EBV infection or evolving lymphoproliferative disease 1, 2

• Comprehensive Metabolic Panel: Elevated transaminases (ALT, AST) and lactate dehydrogenase are common in EBV-associated complications and may persist beyond acute infection 3. Elevated liver enzymes increase suspicion for ongoing EBV-related pathology even when other tests are negative 2

• EBV-Specific Antibody Panel:

  • VCA IgG and IgM
  • EBNA (Epstein-Barr Nuclear Antigen)

  This panel differentiates acute from past infection and identifies chronic active disease 1. The presence of EBNA antibodies indicates infection occurred >6 weeks prior, while absence of EBNA with positive VCA suggests more recent or persistent active infection 1

When to Pursue Advanced Testing

Indicators for Chronic Active EBV Workup

If the patient has persistent symptoms (fever, lymphadenopathy, hepatosplenomegaly lasting >3 months), consider chronic active EBV infection (CAEBV) and order 4:

• Quantitative EBV PCR on peripheral blood: >10^2.5 copies/mg DNA in peripheral blood mononuclear cells suggests CAEBV 4
• Flow cytometry: To identify the cell lineage infected (T-cell, NK-cell, or B-cell), as T-cell and NK-cell variants carry worse prognosis 4

Critical Pitfall to Avoid

Do not rely on heterophile antibody testing (Monospot) in this scenario. Heterophile antibodies decline over months to a year after acute infection 1, making them useless for evaluating complications in someone with prior mono. The heterophile test has 10% false-negative rates even in acute infection 1 and would be expected to be negative in a patient with past infection.

Risk Stratification Based on Splenomegaly

Since splenomegaly persists or has developed, assess for:

• Splenic infarction risk: While rare (0.1-0.5% of IM cases), this is life-threatening 5, 6. The presence of left upper quadrant pain warrants CT abdomen/pelvis with contrast 6

• Lymphoproliferative disease: Persistent splenomegaly beyond 8 weeks raises concern for EBV-associated lymphoproliferative disorders, particularly in the context of T-cell or NK-cell infection 4. This would necessitate tissue biopsy with in situ hybridization for EBV-encoded RNAs (EBERs) if clinically indicated 4

Algorithmic Approach

1. Start with CBC with differential + CMP + EBV antibody panel (VCA IgG/IgM, EBNA)
2. If symptoms >3 months or concerning features: Add quantitative EBV PCR
3. If EBV PCR elevated: Add flow cytometry to identify infected cell lineage
4. If abdominal pain present: Order CT abdomen/pelvis to rule out splenic complications
5. If cytopenias or constitutional symptoms persist: Consider hematology referral for possible bone marrow evaluation and tissue diagnosis

The 20-year-old age group has higher risk for complications compared to younger children 5, 2, making thorough evaluation particularly important in this demographic.